$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
Jazz Reports Mixed Q1 but Xyrem Growth Stays Strong; Lowering FVE to $130 From Virus Impact to Sales
02:19pm, Wednesday, 06'th May 2020Jazz Pharmaceuticals (JAZZ) Q1 2020 Earnings Call Transcript
11:04am, Wednesday, 06'th May 2020
JAZZ earnings call for the period ending March 31, 2020.
Why Jazz Pharmaceuticals Sang Off-Key in Q1
11:00am, Wednesday, 06'th May 2020
Jazz Pharmaceuticals (NASDAQ: JAZZ) ended 2019 on a positive note, with shares up 20%. Jazz stock is down more than 30%, wiping out all of the 2019 gains and then some. Here's why Jazz sang off-key
Edited Transcript of JAZZ earnings conference call or presentation 5-May-20 8:30pm GMT
06:29am, Wednesday, 06'th May 2020
Q1 2020 Jazz Pharmaceuticals PLC Earnings Call
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates
10:45pm, Tuesday, 05'th May 2020
Jazz (JAZZ) delivered earnings and revenue surprises of -31.82% and -0.68%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Jazz Pharmaceuticals Cuts FY20 Sales Guidance From $2.32B-$2.4B To $2.12B-$2.26B Vs. $2.48B Est.
12:00am, Tuesday, 05'th May 2020Should You Buy Jazz Pharmaceuticals (JAZZ) Ahead of Earnings?
02:57pm, Monday, 04'th May 2020
Jazz Pharmaceuticals (JAZZ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Should You Buy Jazz Pharmaceuticals (JAZZ) Ahead of Earnings?
12:00am, Monday, 04'th May 20202 Cheap Healthcare Stocks to Buy Now
11:36am, Sunday, 03'rd May 2020
It's time to shop for healthcare stocks that have suffered so far this year but should rebound in the long term thanks to growth drivers waiting in the wings. The first of these great deals, a pharma
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
The NBA Is Optimistic About Its Return. Here’s Why That Should Matter To You
01:28pm, Friday, 01'st May 2020
By actively and optimistically pursuing a smart and safe restart, the NBA is doing what some of our own elected officials have not been able to do – create a sense of possibility even while explorin
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Sees Large Increase in Short Interest
08:46am, Friday, 01'st May 2020
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 2,950,000 shares, a growth
Jazz Pharma comes up empty in late-stage defibrotide study
01:22pm, Thursday, 30'th Apr 2020
Jazz Pharmaceuticals (NASDAQ:JAZZ) slips 3% premarket on light volume on the heels of disappointing results from a Phase 3 clinical trial evaluating defibrotide for the prevention of hepatic veno-oc
Sign In
Buy JAZZ